the aid library

LIST OPTIONS

Filter

1890

Sort by:

Direction:

Download (462)

View PDF (1576)

Guidelines for Cunducting Clinical Trials of Medicines, Food Supplements, Vaccines, and Medical Devices in Sierra Leone

Pharmacy Board Sierra Leone (2014) C1

Download (343)

View PDF (800)

Instructions for Completing Suspected Adverse Event Reporting Form

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2014) C1

Download (1158)

View PDF (1240)

Manual for Medicines Good Prescribing Practice (Ethiopia)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1

2nd edition

Download (521)

View PDF (1156)

Bangladesh Multiple Indicator Cluster Survey 2012-2013, Progotir Pathey. Key Findings

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh; UNICEF (2014) C1

Download (109)

View PDF (125)

Руководство по самотестированию на ВИЧ и информированию партнеров - Дополнение к сводному руководству по услугам тестирования на ВИЧ

Всемирная организация здравоохранения Всемирная организация здравоохранения (Европа); European Centre for Disease Prevention and Control (ECDC) (2018) C_WHO

ДОПОЛНЕНИЕ СЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ ДЕКАБРЬ 2016 г.

Download (210)

View PDF (166)

AIDSinfo Glossary of HIV/AIDS-Related Terms

AIDSinfo; National Library of Medicine (NIH); Department of Health & Human Services USA AIDSinfo; National Library of Medicine (NIH); Department of Health & Human Services USA (2018) C2

2018 9th Edition Offering information on HIV/AIDS treatment, prevention, and research

Download (121)

View PDF (831)

Philippine Action Plan to Combat AMR: One Health Approach

Phillipine Department of Health (2019) C_WHO

Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c... more

Download (124)

View PDF (163)

Sierra Leone: National Strategy Plan for Combating Antimicrobial Resistance

Ministry of Health and Sanitation Sierra Leone (2018) C_WHO

Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ... more

Download (158)

View PDF (161)

Catalogue of interventions addressing vaccine hesitancy

European Centre for Disease Prevention and Control ECDC (2017) C1

This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource for other countries. The project was developed in the context of ECDC’s support fo... more

Download (86)

View PDF (146)

Sequencing of SARS-CoV-2 - first update

European Centre for Disease Prevention and Control ECDC (2021) CC

This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic... more

Download (120)

View PDF (173)

Ensuring sustainable access to effective antibiotics for EVERYONE - EVERYWHERE

ReAct Action on Antibiotic Resistance (2021) CC

How to address the global crisis in antibiotic research and development. The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ... more

Download (91)

View PDF (138)

WHO Good Governance for Medicines programme. an innovative approach to prevent corruption in the pharmaceutical sector

Baghdadi-Sabeti , G.; and F. Serhan World Health Organization WHO (2010) C_WHO

Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25

Download (136)

View PDF (146)

Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement

World Health Organization WHO (2022) C_WHO

Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij... more

Download (92)

View PDF (116)

Recomendaciones para el Abordaje Terapéutico de Covid-19 en Niños, Niñas y Adolescentes

Ministerio de Salud Argentina Ministerio de Salud Argentina (2021) CC

Guidelines for the care of children and adolescents diagnosed with COVID - 19.

Download (122)

View PDF (180)

WHO technical consultation on preferred product characteristics for drugs used in malaria chemoprevention

World Health Organization WHO (2022) C_WHO

On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t... more

Download (157)

View PDF (181)

WHO pharmaceuticals newsletter - No. 1, 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f... more

Download (119)

View PDF (147)

Access to controlled medicines for pain management in the WHO South-East Asia Region

World Health Organisation (WHO) (2023) C_WHO

The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll... more

Download (92)

View PDF (89)

Guidance on the use of mpox vaccines. Revised edition

Pan American Health Organisation PAHO (2024) CC

Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr... more

Download (41)

View PDF (21)

Cystic Fibrosis - What Is Cystic Fibrosis

National Heart, Lung, and Blood Institute (NHLBI) U.S. Department of Health and Human Services (2024) CC2

The "Cystic Fibrosis Fact Sheet" by the National Heart, Lung, and Blood Institute provides an overview of cystic fibrosis (CF), a chronic and often fatal genetic disorder affecting the respiratory and digestive systems. The document outlines the causes, genetic inheritance patterns, and symptoms of ... more

Download (3)

View PDF (2)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more